Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression

Seasonal Affective Disorder: A Description of the Syndrome and Preliminary Findings With Light Therapy

Rosenthal, N. E. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790120076010 · Cited by 2,385 · see citing works

Notes on the estimation of the numerical density of arbitrary profiles: the edge effect

Gundersen, H. J. G. (1977) · Journal of Microscopy · doi:10.1111/j.1365-2818.1977.tb00062.x · Cited by 1,265 · see citing works

The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia

Swaab, D. F., Fliers, E., & Partiman, T. S. (1985) · Brain Research · doi:10.1016/0006-8993(85)91350-2 · Cited by 847 · see citing works

Neurophysiology of the suprachiasmatic circadian pacemaker in rodents

Meijer, J. H., & Rietveld, W. J. (1989) · Physiological Reviews · doi:10.1152/physrev.1989.69.3.671 · Cited by 737 · see citing works

Increased Numbers of Corticotropin-Releasing Hormone Expressing Neurons in the Hypothalamic Paraventricular Nucleus of Depressed Patients

Raadsheer, F. C., Hoogendijk, W. J. G., Stam, F. C., Tilders, F. J. H., & Swaab, D. F. (2008) · Neuroendocrinology · doi:10.1159/000126778 · Cited by 667 · see citing works

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior

Stenzel‐Poore, M. P., Heinrichs, S. C., Rivest, S., Koob, G. F., & Vale, W. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02579.1994 · Cited by 468 · see citing works

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

Raadsheer, F. C., van Heerikhuize, J. J., Lucassen, P. J., Hoogendijk, W. J. G., Tilders, F. J. H., & Swaab, D. F. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1372 · Cited by 411 · see citing works

Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality

Souêtre, E., Salvati, E., Belugou, J.-L., Pringuey, D., Candito, M., Krebs, B., Ardisson, J.-L., & Darcourt, G. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90207-2 · Cited by 396 · see citing works

Bright Light Treatment of Winter Depression: A Placebo-Controlled Trial

Eastman, C. I., Young, M. A., Fogg, L. F., Liu, L., & Meaden, P. M. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.10.883 · Cited by 347 · see citing works

Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls

Deuschle, M., Schweiger, U., Weber, B., Gotthardt, U., Körner, A., Schmider, J., Standhardt, H., Lammers, C.-H., & Heuser, I. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3689 · Cited by 344 · see citing works

Pre‐and Postmortem Influences on Brain RNA

BARTON, A. J. L., Pearson, R. C. A., Najlerahim, A., & Harrison, P. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03532.x · Cited by 269 · see citing works

Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release

Kalsbeek, A., Buijs, R. M., van Heerikhuize, J. J., Arts, M., & van der Woude, T. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)90927-2 · Cited by 226 · see citing works

Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging

Hofman, M. A., & Swaab, D. F. (1994) · Brain Research · doi:10.1016/0006-8993(94)90689-0 · Cited by 215 · see citing works

Chapter 21 The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia

Holsboer, F., Spengler, D., & Heuser, I. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64586-0 · Cited by 158 · see citing works

Particle size‐shape distributions: the general spheroid problem: II. Stochastic model and practical guide

Cruz-Orive, L. M. (1978) · Journal of Microscopy · doi:10.1111/j.1365-2818.1978.tb01162.x · Cited by 149 · see citing works

Depletion of brain serotonin by 5,7-DHT modifies hamster circadian rhythm response to light

Morin, L. P., & Blanchard, J. H. (1991) · Brain Research · doi:10.1016/0006-8993(91)91696-x · Cited by 146 · see citing works

Loss of vasopressin-immunoreactive neurons in alcoholics is dose-related and time-dependent

Harding, A., Halliday, G. M., Ng, J. L. F., Harper, C., & Kril, J. J. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00577-3 · Cited by 143 · see citing works

Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease

Salehi, A., Verhaagen, J., Dijkhuizen, P. A., & Swaab, D. F. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00273-4 · Cited by 135 · see citing works

The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease

Goudsmit, E., Hofman, M. A., Fliers, E., & Swaab, F. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90114-f · Cited by 133 · see citing works

Chronic Alcohol Consumption and Withdrawal Do Not Induce Cell Death in the Suprachiasmatic Nucleus, But Lead to Irreversible Depression of Peptide Immunoreactivity and mRNA Levels

Madeira, M. D., Andrade, J. P., Lieberman, A. R., Sousa, N., Almeida, O. F. X., & Paula-Barbosa, M. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01302.1997 · Cited by 108 · see citing works

Diurnal and Seasonal Rhythms of Neuronal Activity in the Suprachiasmatic Nucleus of Humans

Hofman, M. A., & Swaab, D. F. (1993) · Journal of Biological Rhythms · doi:10.1177/074873049300800402 · Cited by 102 · see citing works

Clinical and chronobiological effects of light therapy on nonseasonal affective disorders

Yamada, N., Martin-Iverson, M. T., Daimon, K., Tsujimoto, T., & Takahashi, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00221-n · Cited by 98 · see citing works

Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus

Salehi, A., Lucassen, P. J., Pool, C. W., Gonatas, N. K., Ravid, R., & Swaab, D. F. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90291-7 · Cited by 98 · see citing works

Age‐related increase in the total number of corticotropin‐releasing hormone neurons in the human paraventricular nucleus in controls and alzheimer's disease: Comparison of the disector with an unfolding method

Raadsheer, F. C., Oorschot, D. E., Verwer, R. W. H., Tilders, F. J. H., & Swaab, D. F. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903390311 · Cited by 76 · see citing works

Chapter 23 Biological rhythms in the human life cycle and their relationship to functional changes in the suprachiasmatic nucleus

Swaab, D. F., Van Someren, E. J. W., Zhou, J. N., & Hofman, M. A. (1996) · Progress in Brain Research · doi:10.1016/s0079-6123(08)60418-5 · Cited by 75 · see citing works

Effect of pre- and postmortem variables on specific mRNA levels in human brain

Burke, W. J., O’Malley, K. L., Chung, H. D., Harmon, S., Miller, J. P., & van den Berg, L. H. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90018-s · Cited by 71 · see citing works

Effects of parachlorophenylalanine and 5, 6-dihydroxytryptamine on the free-running rhythms of locomotor activity and plasma corticosterone in the rat exposed to continuous light

Honma, K., Watanabe, K., & Hiroshige, T. (1979) · Brain Research · doi:10.1016/0006-8993(79)90402-5 · Cited by 65 · see citing works

Chronobiological Theories of Nonseasonal Affective Disorders and Their Implications for Treatment

van den Hoofdakker, R. H. (1994) · Journal of Biological Rhythms · doi:10.1177/074873049400900206 · Cited by 61 · see citing works

Differential regional and cellular distribution of β-amyloid precursor protein messenger RNAs containing and lacking the kunitz protease inhibitor domain in the brain of human, rat and mouse

Solà, C., Mengod, G., Probst, A., & Palacios, J. M. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90304-x · Cited by 54 · see citing works

Diurnal rhythm of vasopressin mRNA species in the rat suprachiasmatic nucleus: independence of neuroendocrine modulation and maintenance in explant culture

Carter, D., & Murphy, D. (1989) · Molecular Brain Research · doi:10.1016/0169-328x(89)90069-7 · Cited by 47 · see citing works

The diurnal expression of genes encoding vasopressin and vasoactive intestinal peptide within the rat suprachiasmatic nucleus is influenced by circulating glucocorticoids

Larsen, P. J., Vrang, N., Møller, M., Jessop, D. S., Lightman, S. L., Chowdrey, H. S., & Mikkelsen, J. D. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90021-3 · Cited by 39 · see citing works

In situ hybridization for vasopressin mRNA in the human supraoptic and paraventricular nucleus; quantitative aspects of formalin-fixed paraffin-embedded tissue sections as compared to cryostat sections

Lucassen, P. J., Goudsmit, E., Pool, C. W., Mengod, G., Palacios, J. M., Raadsheer, F. C., Guldenaar, S. E. F., & Swaab, D. F. (1995) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)00152-7 · Cited by 38 · see citing works

Expression of the vasopressin and oxytocin genes in human hypothalami

Mohr, E., Hillers, M., Ivell, R., Haulica, I. D., & Richter, D. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80069-7 · Cited by 37 · see citing works

The use ofin situ hybridization histochemistry for the study of neuropeptide gene expression in the human brain

Mengod, G., Charli, J., & PALACIOS, J. M. (1990) · Cellular and Molecular Neurobiology · doi:10.1007/bf00733639 · Cited by 30 · see citing works

A neurophysiological study of a lithium-sensitive phosphoinositide system in the hamster suprachiasmatic (SCN) biological clock in vitro

Mason, R., & Biello, S. M. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90734-o · Cited by 30 · see citing works

Chapter 4 In situ hybridization histochemistry in the human hypothalamus

Mengod, G., Goudsmit, E., Probst, A., & Palacios, J. M. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64562-8 · Cited by 21 · see citing works

A study on postmortem stability of vasopressin messenger RNA in rat brain compared with those in total RNA and ribosomal RNA

Noguchí, I., Arai, H., & Iizuka, R. (1991) · Journal of Neural Transmission · doi:10.1007/bf01253387 · Cited by 18 · see citing works

A study of non-isotopic in situ hybridization histochemistry on postmortem changes in vasopressin mRNA in rat brain

Arai, H., Noguchí, I., Sagi, N., Moroji, T., & Iizuka, R. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90563-6 · Cited by 17 · see citing works

Study of pro-opiomelanocortin mRNA expression in human postmortem pituitaries

Mengod, G., Vivanco, M. D., Christnacher, A., Probst, A., & Palacios, J. M. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90103-5 · Cited by 17 · see citing works

Morphometric analysis of vasopressin and vasoactive intestinal polypeptide neurons in the human suprachiasmatic nucleus: influence of microwave treatment

Zhou, J., Hofman, M. A., & Swaab, D. F. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00787-1 · Cited by 14 · see citing works

The stress system in the human brain in depression and neurodegeneration

Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984 · see citing works

Sleep, insomnia, and depression

Riemann, D. W., Krone, L. B., Wulff, K., & Nissen, C. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0411-y · Cited by 863 · see citing works

Effect of Bright Light and Melatonin on Cognitive and Noncognitive Function in Elderly Residents of Group Care Facilities: A Randomized Controlled Trial

Riemersma-van der Lek, R. F. (2008) · JAMA · doi:10.1001/jama.299.22.2642 · Cited by 803 · see citing works

Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application

Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 549 · see citing works

The stress system in depression and neurodegeneration: Focus on the human hypothalamus

Bao, A., Meynen, G., & Swaab, D. F. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.005 · Cited by 547 · see citing works

Vasopressin: Behavioral roles of an “original” neuropeptide

Caldwell, H. K., Lee, H.-J., Macbeth, A. H., & Young, W. S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.007 · Cited by 504 · see citing works

Depression Is Associated With Decreased 25-Hydroxyvitamin D and Increased Parathyroid Hormone Levels in Older Adults

Hoogendijk, W. J. G., Lips, P. T. A. M., Dik, M. G., Deeg, D. J. H., Beekman, A. T. F., & Penninx, B. W. J. H. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.508 · Cited by 442 · see citing works

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

Holmes, A., Heilig, M. A., Rupniak, N. M. J., Steckler, T., & Griebel, G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.09.011 · Cited by 401 · see citing works

The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system

Buijs, R. M., van Eden, C. G., Goncharuk, V. D., & Kalsbeek, A. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1770017 · Cited by 387 · see citing works

Living by the clock: The circadian pacemaker in older people

Hofman, M. A., & Swaab, D. F. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.07.001 · Cited by 335 · see citing works

Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders

Anisman, H., Merali, Z., & Hayley, S. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 334 · see citing works

The neuropathology of primary mood disorder

Harrison, P. J. (2002) · Brain · doi:10.1093/brain/awf149 · Cited by 321 · see citing works

Bright Light Treatment in Elderly Patients With Nonseasonal Major Depressive Disorder: A Randomized Placebo-Controlled Trial

Lieverse, R., Van Someren, E. J. W., Nielen, M. M. A., Uitdehaag, B. M. J., Smit, J. H., & Hoogendijk, W. J. G. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.183 · Cited by 261 · see citing works

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder

Kasper, S. F., Hajak, G., Wulff, K., Hoogendijk, W. J. G., Montejo, A. L., Smeraldi, E., RYBAKOWSKI, J. K., Quera-Salva, M.-A., Wirz‐Justice, A., Picarel-Blanchot, F., et al. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05347blu · Cited by 256 · see citing works

Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances

Wang, S.-S., Kamphuis, W., Huitinga, I., Zhou, J.-N., & Swaab, D. F. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.38 · Cited by 250 · see citing works

Biochemical and molecular studies using human autopsy brain tissue

Hynd, M. R., Lewohl, J. M., Scott, H. L., & Dodd, P. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01747.x · Cited by 237 · see citing works

Effects of circadian disruption on the cardiometabolic system

Rüger, M., & Scheer, F. A. J. L. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-009-9122-8 · Cited by 232 · see citing works

The impact of the circadian timing system on cardiovascular and metabolic function

Morris, C. J., Yang, J. N., & Scheer, F. A. J. L. (2012) · Progress in Brain Research · doi:10.1016/b978-0-444-59427-3.00019-8 · Cited by 215 · see citing works

The human hypothalamus in mood disorders: The HPA axis in the center

Bao, A.-M., & Swaab, D. F. (2019) · IBRO Reports · doi:10.1016/j.ibror.2018.11.008 · Cited by 212 · see citing works

Cellular Circadian Clocks in Mood Disorders

McCarthy, M. J., & Welsh, D. K. (2012) · Journal of Biological Rhythms · doi:10.1177/0748730412456367 · Cited by 203 · see citing works

Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus

Vadnie, C. A., & McClung, C. A. (2017) · Neural Plasticity · doi:10.1155/2017/1504507 · Cited by 199 · see citing works

Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: Focus on vasopressin and glyoxalase-I

Landgraf, R., Kessler, M. S., Bunck, M., Murgatroyd, C., Spengler, D., Zimbelmann, M., Nußbaumer, M., Czibere, L., Turck, C. W., Singewald, N., et al. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.003 · Cited by 199 · see citing works

Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Griebel, G., & Holsboer, F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3702 · Cited by 194 · see citing works

Vasopressin and the Output of the Hypothalamic Biological Clock

Kalsbeek, A., Fliers, E., Hofman, M. A., Swaab, D. F., & Buijs, R. M. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.01956.x · Cited by 192 · see citing works

Organization of circadian functions: interaction with the body

Buijs, R. M., Scheer, F. A. J. L., Kreier, F., Yi, C., Bos, N. P. A., Goncharuk, V. D., & Kalsbeek, A. (2006) · Progress in brain research · doi:10.1016/s0079-6123(06)53020-1 · Cited by 189 · see citing works

Sex Hormone Receptors Are Present in the Human Suprachiasmatic Nucleus

Kruijver, F. P. M., & Swaab, D. F. (2002) · Neuroendocrinology · doi:10.1159/000057339 · Cited by 187 · see citing works

Residential segregation, geographic proximity and type of services used: Evidence for racial/ethnic disparities in mental health

Dinwiddie, G. Y., Gaskin, D. J., Chan, K. S., Norrington, J., & McCleary, R. M. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.11.024 · Cited by 178 · see citing works

Colocalization of corticotropin-releasing hormone and oestrogen receptor-α in the paraventricular nucleus of the hypothalamus in mood disorders

Bao, A., Hestiantoro, A., Someren, E. J. W. V., Swaab, D. F., & Zhou, J. (2005) · Brain · doi:10.1093/brain/awh448 · Cited by 172 · see citing works

Elevated neuron number in the limbic thalamus in major depression

Young, K. A., Holcomb, L. A., Yazdani, U., Hicks, P. B., & German, D. C. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1270 · Cited by 169 · see citing works

Innovative Approaches for the Treatment of Depression: Targeting the HPA Axis

THOMSON, F. J., & Craighead, M. W. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9518-3 · Cited by 155 · see citing works

Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression

Hickie, I. B., Naismith, S. L., Robillard, R., Scott, E. M., & Hermens, D. F. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-79 · Cited by 148 · see citing works

The role of sleep in bipolar disorder

Gold, A. K., & Sylvia, L. G. (2016) · Nature and Science of Sleep · doi:10.2147/nss.s85754 · Cited by 147 · see citing works

The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development

Ring, R. H. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382241 · Cited by 141 · see citing works

Circadian disruption and SCN control of energy metabolism

Kalsbeek, A., Scheer, F. A., Perreau-Lenz, S., La Fleur, S. E., Yi, C.-X., Fliers, E., & Buijs, R. M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.021 · Cited by 133 · see citing works

Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression

Wu, Y., Ursinus, J., Zhou, J., Scheer, F. A. J. L., Ai-Min, B., Jockers, R., van Heerikhuize, J. J., & Swaab, D. F. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.12.025 · Cited by 130 · see citing works

Exploring the role of neuropeptides in depression and anxiety

Rana, T., Behl, T., Sehgal, A., Singh, S., Sharma, N., Abdeen, A., Ibrahim, S. F., Mani, V., Iqbal, M. S., Bhatia, S., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110478 · Cited by 126 · see citing works

Neurotransmitters of the suprachiasmatic nuclei

Reghunandanan, V., & Reghunandanan, R. (2006) · Journal of Circadian Rhythms · doi:10.1186/1740-3391-4-2 · Cited by 118 · see citing works

Estrogen‐receptor‐β distribution in the human hypothalamus: Similarities and differences with ERα distribution

Kruijver, F. P. M., Balesar, R. A., Espila, A. M., Unmehopa, U. A., & Swaab, D. F. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10899 · Cited by 116 · see citing works

Endocrine disturbances in depression

Tichomirowa, M. A., Keck, M. E., Schneider, H. J., Páez-Pereda, M., Renner, U., Holsboer, F., & Stalla, G. K. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345535 · Cited by 111 · see citing works

Neural Substrates of Psychostimulant Withdrawal-Induced Anhedonia

D’Souza, M. S., & Markou, A. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_20 · Cited by 107 · see citing works

The circadian system and the balance of the autonomic nervous system

Buijs, R. M., Escobar, C., & Swaab, D. F. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53491-0.00015-8 · Cited by 100 · see citing works

Dysregulation of GABAergic Neurotransmission in Mood Disorders

Bielau, H., Steiner, J. H., Mawrin, C., Trübner, K., Brisch, R., Meyer-Lotz, G., Brodhun, M., Dobrowolny, H., Baumann, B., Gos, T., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.081 · Cited by 90 · see citing works

Functional plasticity of the circadian timing system in old age: light exposure

Someren, E. J. W. V., Riemersma, R. F., & Swaab, D. F. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)38080-4 · Cited by 90 · see citing works

Nocturia and depression

Asplund, R., Henriksson, S., Johansson, S., & Isacsson, G. (2004) · British Journal of Urology · doi:10.1111/j.1464-410x.2004.04835.x · Cited by 84 · see citing works

Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related Disorders

Griebel, G., Stemmelin, J., Gal, C. S., & Soubrié, P. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764797 · Cited by 84 · see citing works

Chronic unpredictable stress induces a reversible change of PER2 rhythm in the suprachiasmatic nucleus

Jiang, W., Li, S., Zhou, S., Sun, Y., Shi, J., & Lü, L. (2011) · Brain Research · doi:10.1016/j.brainres.2011.05.001 · Cited by 83 · see citing works

The Vasopressin V_1bReceptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies

Griebel, G., Beeské, S., & Stahl, S. M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07804 · Cited by 81 · see citing works

G protein-linked signaling pathways in bipolar and major depressive disorders

Tomita, H., Ziegler, M. E., Kim, H. B., Evans, S. J., Choudary, P. V., Li, J. Z., Meng, F., Dai, M., Myers, R., Neal, C. R., et al. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00297 · Cited by 81 · see citing works

Suprachiasmatic Nucleus Neuropeptide Expression in Patients with Huntington's Disease

van Wamelen, D. J., Aziz, N. A., Anink, J. J., van Steenhoven, R., Angeloni, D., FRASCHINI, F., Jockers, R., Roos, R. A. C., & Swaab, D. F. (2012) · SLEEP · doi:10.5665/sleep.2314 · Cited by 77 · see citing works

Sexually Dimorphic Changes of Hypocretin (Orexin) in Depression

Lu, J., Zhao, J., Balesar, R., Fronczek, R., Zhu, Q.-B., Wu, X.-Y., Hu, S.-H., Bao, A.-M., & Swaab, D. F. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.043 · Cited by 77 · see citing works

Circadian Rhythms of Perineuronal Net Composition

Pantazopoulos, H., Gisabella, B., Rexrode, L., Benefield, D., Yıldız, E., Seltzer, P., Valeri, J., Chelini, G., Reich, A., Ardelt, M., et al. (2020) · eNeuro · doi:10.1523/eneuro.0034-19.2020 · Cited by 73 · see citing works

Corticotropin-Releasing Hormone, Glutamate, and γ-Aminobutyric Acid in Depression

Gao, S., & Bao, A. (2010) · The Neuroscientist · doi:10.1177/1073858410361780 · Cited by 71 · see citing works

Effect of lesioning the suprachiasmatic nuclei on behavioral despair in rats

Tataroğlu, Ö., Aksoy, A., Yılmaz, A., & Canbeyli, R. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.063 · Cited by 69 · see citing works

Neuropeptides in Hypothalamic Neuronal Disorders

Swaab, D. F. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)40003-5 · Cited by 68 · see citing works

The hypothalamus in episodic brain disorders

Overeem, S., van Vliet, J. A., Lammers, G. J., Zitman, F. G., Swaab, D. F., & Ferrari, M. D. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00191-6 · Cited by 68 · see citing works

Suprachiasmatic nucleus projection to the medial prefrontal cortex: a viral transneuronal tracing study

Sylvester, C. M., Krout, K. E., & Loewy, A. D. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00361-5 · Cited by 64 · see citing works

Decreased Numbers of Somatostatin-Expressing Neurons in the Amygdala of Subjects With Bipolar Disorder or Schizophrenia: Relationship to Circadian Rhythms

Pantazopoulos, H., Wiseman, J. T., Markota, M., Ehrenfeld, L., & Berretta, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.04.006 · Cited by 64 · see citing works

Circadian insights into the biology of depression: Symptoms, treatments and animal models

Mendoza, J. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112186 · Cited by 64 · see citing works

Corticotropin-Releasing Hormone and Arginine Vasopressin in Depression

Bao, A., & Swaab, D. F. (2010) · Vitamins and hormones · doi:10.1016/s0083-6729(10)82018-7 · Cited by 60 · see citing works

Depressive Symptoms Increase the Incidence of Nocturia: Tampere Aging Male Urologic Study (TAMUS)

Häkkinen, J., Shiri, R., Koskimäki, J. E., Tammela, T. L. J., Auvinen, A. P., & Hakama, M. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.01.037 · Cited by 59 · see citing works

Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat

Overstreet, D. H., & Griebel, G. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.07.021 · Cited by 58 · see citing works

Androgens and male behavior

Gooren, L. J., & Kruijver, F. P. M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00366-0 · Cited by 57 · see citing works

Sex differences in stress-related disorders: Major depressive disorder, bipolar disorder, and posttraumatic stress disorder

Swaab, D. F., & Bao, A. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00023-0 · Cited by 56 · see citing works

Neuropeptides: Relevance in treatment of depression and anxiety disorders

Madaan, V., & Wilson, D. R. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.6.1395255 · Cited by 54 · see citing works

Neuropeptides involved in the pathophysiology of schizophrenia and major depression

de Wied, D., & Sigling, H. O. (2002) · Neurotoxicity Research · doi:10.1080/10298420290031432 · Cited by 52 · see citing works

Structural studies of the hypothalamus and its nuclei in mood disorders

Schindler, S., Geyer, S., Strauß, M., Anwander, A., Hegerl, U., Turner, R., & Schönknecht, P. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.06.005 · Cited by 49 · see citing works

Hypothalamus enlargement in mood disorders

Schindler, S., Schmidt, L., Stroske, M., Storch, M., Anwander, A., Trampel, R., Strauß, M., Hegerl, U., Geyer, S., & Schönknecht, P. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12958 · Cited by 48 · see citing works

The antidepressant effect of light therapy from retinal projections.

Li, X., & Li, X. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0210-1 · Cited by 47 · see citing works

Seasonal changes in day length induce multisynaptic neurotransmitter switching to regulate hypothalamic network activity and behavior

Porcu, A., Nilsson, A., Booreddy, S., Barnes, S. A., Welsh, D. K., & Dulcis, D. (2022) · Science Advances · doi:10.1126/sciadv.abn9867 · Cited by 47 · see citing works

Further Immunohistochemical Evidence for Impaired NO Signaling in the Hypothalamus of Depressed Patients

Bernstein, H., Heinemann, A., Krell, D., Mawrin, C., Bielau, H., Dános, P., Diekmann, S., Keilhoff, G., Bogerts, B., & Baumann, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04613.x · Cited by 45 · see citing works

Bipolar disorder

Smıth, D. J., Whitham, E. A., & Ghaemi, S. N. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00015-2 · Cited by 44 · see citing works

Daily Variations in Type II Iodothyronine Deiodinase Activity in the Rat Brain as Controlled by the Biological Clock

Kalsbeek, A., Buijs, R. M., van Schaik, R., Kaptein, E., Visser, T. J., Zandieh‐Doulabi, B., & Fliers, E. (2004) · Endocrinology · doi:10.1210/en.2004-0763 · Cited by 43 · see citing works

Glucocorticoids suppress vasopressin gene expression in human suprachiasmatic nucleus

Liu, R., Unmehopa, U. A., Zhou, J., & Swaab, D. F. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.10.002 · Cited by 42 · see citing works

Prenatal hypoxia impairs circadian synchronisation and response of the biological clock to light in adult rats

Joseph, V., Mamet, J., Lee, F., Dalmaz, Y., & Reeth, O. V. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.022236 · Cited by 40 · see citing works

Abnormal Expression of Synaptophysin, SNAP-25, and Synaptotagmin 1 in the Hippocampus of Kainic Acid-Exposed Rats with Behavioral Deficits

Zhang, F., Sun, Q., Zheng, X., Lin, Y.-T., Shang, W., Wang, A.-H., Duan, R., & Chi, Z.-F. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0068-3 · Cited by 39 · see citing works

Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome

Corrêa-da-Silva, F., Fliers, E., Swaab, D., & Yi, C. (2021) · Journal of neuroendocrinology · doi:10.1111/jne.12994 · Cited by 34 · see citing works

Age-related spatial cognitive impairment is correlated with increase of synaptotagmin 1 in dorsal hippocampus in SAMP8 mice

Chen, G.-H., Wang, Y., Song, Q., Yang, Q., Zhou, J., & Liu, R. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.001 · Cited by 37 · see citing works

Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression

Paschos, K. A., Veletza, S. V., & Chatzaki, Ε. (2009) · CNS Drugs · doi:10.2165/11310830-000000000-00000 · Cited by 36 · see citing works

Vasopressin V1B receptor antagonists as potential antidepressants

Chaki, S. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab013 · Cited by 34 · see citing works

Alterations to Embryonic Serotonin Change Aggression and Fearfulness

Dennis, R. L., Fahey, A. G., & Cheng, H. W. (2013) · Aggressive Behavior · doi:10.1002/ab.21459 · Cited by 34 · see citing works

Pretreatment depressive symptoms and treatment modality predict post-treatment disease-specific quality of life among patients with localized prostate cancer

Mohamed, N. E., Bovbjerg, D. H., Montgomery, G. H., Hall, S. J., & Diefenbach, M. A. (2012) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2011.02.002 · Cited by 33 · see citing works

Neurotransmitters and neuropeptides in depression

Bao, A., Ruhé, H. G., Gao, S., & Swaab, D. F. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00008-5 · Cited by 30 · see citing works

The art of matching brain tissue from patients and controls for postmortem research

Bao, A., & Swaab, D. F. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00015-3 · Cited by 29 · see citing works

Therapeutic Strategies for Circadian Rhythm and Sleep Disturbances in Huntington Disease

van Wamelen, D. J., Roos, R. A. C., & Aziz, N. A. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.45 · Cited by 28 · see citing works

Further genetic evidence implicates the vasopressin system in childhood‐onset mood disorders

Dempster, E. L., Burcescu, I., Wigg, K. G., Kiss, E., Baji, I., Gádoros, J., Tamás, Z., Kapornai, K., Daróczy, G., Kennedy, J. L., et al. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06930.x · Cited by 28 · see citing works

Vasopressin–neurophysin and DST in major depression: Relationship with suicidal behavior

Pitchot, W., Scantamburlo, G., Pinto, E., Hansenne, M., Reggers, J., Ansseau, M., & Legros, J.-J. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.07.007 · Cited by 26 · see citing works

AVP- and OT-neurophysins response to apomorphine and clonidine in major depression

Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.04.015 · Cited by 26 · see citing works

Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders

Kanes, S., Dennie, L., & Perera, P. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s402831 · Cited by 25 · see citing works

Relation between Corticotropin-Releasing Hormone Neuron Number in the Hypothalamic Paraventricular Nucleus and Depressive State in Alzheimer’s Disease

Meynen, G., Unmehopa, U. A., Hofman, M. A., Swaab, D. F., & Hoogendijk, W. J. G. (2007) · Neuroendocrinology · doi:10.1159/000100582 · Cited by 25 · see citing works

Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression

Wu, X., Balesar, R. A., Lü, J., Farajnia, S., Zhu, Q., Huang, M., Bao, A., & Swaab, D. F. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1442-y · Cited by 24 · see citing works

The hypothalamus and neuropsychiatric disorders: psychiatry meets microscopy

Bernstein, H., Dobrowolny, H., Bogerts, B., Keilhoff, G., & Steiner, J. H. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2849-3 · Cited by 24 · see citing works

The Suprachiasmatic Nucleus Regulates Anxiety-Like Behavior in Mice

Vadnie, C. A., Petersen, K. A., Eberhardt, L. A., Hildebrand, M. A., Cerwensky, A. J., Zhang, H., Burns, J. N., Becker‐Krail, D. D., DePoy, L. M., Logan, R. W., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.765850 · Cited by 23 · see citing works

Pharmacological Manipulation of the Circadian Clock: A Possible Approach to the Management of Bipolar Disorder

Porcu, A., Gonzalez, R., & McCarthy, M. J. (2019) · CNS Drugs · doi:10.1007/s40263-019-00673-9 · Cited by 22 · see citing works

Endocrinologie et psychiatrie

Duval, F. (2004) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(03)00099-3 · Cited by 21 · see citing works

Paraventricular Nucleus Neuropeptide Expression in Huntington's Disease Patients

van Wamelen, D. J., Aziz, N. A., Anink, J. J., Roos, R. A. C., & Swaab, D. F. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00565.x · Cited by 20 · see citing works

Monoaminergic control of vasopressin and VIP expression in the mouse suprachiasmatic nucleus

Vacher, C., Frétier, P., Créminon, C., Seif, I., Maeyer, E. D., Calas, A., & Hardin‐Pouzet, H. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10529 · Cited by 20 · see citing works

Neurobiology of depression

Zandio, M., Ferrín, M., & Cuesta, M. J. (2009) · Anales del Sistema Sanitario de Navarra · doi:10.23938/assn.0841 · Cited by 19 · see citing works

Molecular mechanisms of circadian rhythm and its influence on the pharmacokinetics of drugs

Vasdev, N., Rajpoot, K., & Tekade, R. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814425-1.00002-4 · Cited by 19 · see citing works

Vasopressin and oxytocin beyond the pituitary in the human brain

Møller, M. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-820107-7.00002-1 · Cited by 18 · see citing works

Class A and C GPCR Dimers in Neurodegenerative Diseases

Moreira, I. S., Caniceiro, A. B., Bueschbell, B., & Schiedel, A. C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220327221830 · Cited by 18 · see citing works

Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression

Wu, X., Balesar, R. A., Lü, J., Farajnia, S., Zhu, Q., Huang, M., Bao, A., & Swaab, D. F. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1442-y · Cited by 24 · see citing works

Decreased Vasopressin Gene Expression in the Biological Clock of Alzheimer Disease Patients With and Without Depression

Liu, R. Y., Zhou, J., Hoogendijk, W. J. G., van Heerikhuize, J. J., Kamphorst, W., Unmehopa, U. A., Hofman, M. A., & Swaab, D. F. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.4.314 · Cited by 157 · see citing works

Circadian changes in arginine vasopressin level in the suprachiasmatic nuclei in the rat

Yamase, K., Takahashi, S., Nomura, K., Haruta, K., & Kawashima, S. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90409-m · Cited by 57 · see citing works

Circadian variation of arginine-vasopressin messenger RNA in the rat suprachiasmatic nucleus

Cagampang, F. R. A., Yang, J., Nakayama, Y., Fukuhara, C., & Inouye, S. T. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90130-9 · Cited by 85 · see citing works

Increased Arginine Vasopressin mRNA Expression in the Human Hypothalamus in Depression: A Preliminary Report

Meynen, G., Unmehopa, U. A., van Heerikhuize, J. J., Hofman, M. A., Swaab, D. F., & Hoogendijk, W. J. G. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.12.010 · Cited by 108 · see citing works